Instil Bio Inc.

09/16/2021 | Press release | Distributed by Public on 09/16/2021 05:01

Instil Bio Presents Subset Analysis of Patients with Checkpoint-Refractory Advanced Melanoma from Compassionate Use Study at 2021 ESMO Congress